Covid-19 vaccine (Sk Bioscience)

N/A

Report date: 2023/01/18 11:32:16

Base Information

Drug NameCovid-19 vaccine (Sk Bioscience)
Drug Alias NameSKYCovioneGBP-510
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2022/06/29
Country/TerritoryUkraineVietnamThailand +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSk Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcSk Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeJ07BX03
Related LinksN/A